Knockdown of iPLA2γ enhances cisplatin-induced apoptosis by increasing ROS-dependent peroxidation of mitochondrial phospholipids in bladder cancer cells
-
Published:2024-08
Issue:
Volume:220
Page:301-311
-
ISSN:0891-5849
-
Container-title:Free Radical Biology and Medicine
-
language:en
-
Short-container-title:Free Radical Biology and Medicine
Author:
Nakayama Satoko,
Yoda Emiko,
Yamashita Saki,
Takamatsu Yuka,
Suzuki Yasutomo,
Kondo Yukihiro,
Hara ShuntaroORCID
Reference56 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021
2. Treatment of muscle-invasive and advanced bladder cancer in 2020;Patel;CA Cancer J. Clin.,2020
3. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J. Clin. Oncol.,2000
4. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J. Clin. Oncol.,2005
5. Molecular mechanisms of cisplatin resistance;Galluzzi;Oncogene,2012